Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Revisiting the Use of Deep Temporalis Fascia Grafts in Ophthalmology.
Razlog E, Denoyer A, Baillif S, Arndt C, Dubernard X, Caujolle JP, Nahon-Esteve S, Martel A. Razlog E, et al. Among authors: baillif s. Semin Ophthalmol. 2024 Apr 25:1-9. doi: 10.1080/08820538.2024.2346756. Online ahead of print. Semin Ophthalmol. 2024. PMID: 38661124
[Blue light and intraocular lenses (IOLs): Beliefs and realities].
Desmettre T, Baillif S, Mathis T, Gatinel D, Mainster M. Desmettre T, et al. Among authors: baillif s. J Fr Ophtalmol. 2024 Feb;47(2):104043. doi: 10.1016/j.jfo.2023.104043. Epub 2024 Jan 18. J Fr Ophtalmol. 2024. PMID: 38241770 Review. French.
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. Proteau S, et al. Among authors: baillif s. EMBO Mol Med. 2023 Dec 7;15(12):e17719. doi: 10.15252/emmm.202317719. Epub 2023 Nov 15. EMBO Mol Med. 2023. PMID: 37966164 Free PMC article.
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ, Lassalle S, Martel A, Nahon-Estève S, Macocco A, Zahaf K, Lalvee S, Fayada J, Lespinet-Fabre V, Bordone O, Pedeutour F, Baillif S, Hofman P. Lamas NJ, et al. Among authors: baillif s. Pathology. 2023 Dec;55(7):929-944. doi: 10.1016/j.pathol.2023.08.003. Epub 2023 Sep 22. Pathology. 2023. PMID: 37863710 Free article.
150 results